Assenagon Asset Management
SRPT icon

Assenagon Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Assenagon Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.17M Buy
+454,375
New +$8.59M 0.01% 566
2025
Q4 		– Sell
-29,482
Closed -$568K – 1253
2025
Q3 		$568K Sell
29,482
-838,457
-97% -$14.9M ﹤0.01% 1032
2025
Q2 		$14.8M Buy
867,939
+155,358
+22% +$6.63M 0.02% 401
2025
Q1 		$45.5M Buy
712,581
+580,123
+438% +$61.1M 0.08% 222
2024
Q4 		$16.1M Sell
132,458
-217,594
-62% -$26.7M 0.03% 395
2024
Q3 		$43.7M Sell
350,052
-9,644
-3% -$1.33M 0.08% 201
2024
Q2 		$56.8M Sell
359,696
-77,994
-18% -$10M 0.13% 126
2024
Q1 		$56.7M Buy
437,690
+53,911
+14% +$6.6M 0.13% 119
2023
Q4 		$37M Sell
383,779
-44,554
-10% -$4.27M 0.1% 164
2023
Q3 		$51.9M Sell
428,333
-297,454
-41% -$33.6M 0.16% 113
2023
Q2 		$83.1M Buy
725,787
+116,639
+19% +$15M 0.29% 58
2023
Q1 		$84M Sell
609,148
-123,384
-17% -$16M 0.3% 67
2022
Q4 		$94.9M Sell
732,532
-396,484
-35% -$45.9M 0.34% 62
2022
Q3 		$125M Buy
1,129,016
+685,845
+155% +$69.1M 0.48% 44
2022
Q2 		$33.2M Sell
443,171
-107,849
-20% -$7.93M 0.12% 161
2022
Q1 		$43M Buy
551,020
+332,503
+152% +$25.5M 0.12% 147
2021
Q4 		$19.7M Buy
218,517
+214,664
+5,571% +$18.4M 0.06% 212
2021
Q3 		$356K Buy
+3,853
New +$297K ﹤0.01% 1125
2020
Q4 		– Sell
-66,590
Closed -$9.35M – 1244
2020
Q3 		$9.35M Buy
+66,590
New +$10.1M 0.05% 207
2020
Q1 		– Sell
-6,663
Closed -$860K – 979
2019
Q4 		$860K Buy
+6,663
New +$673K 0.01% 593
2019
Q1 		– Sell
-15,522
Closed -$1.69M – 1107
2018
Q4 		$1.69M Buy
+15,522
New +$1.94M 0.02% 502

Other funds holding SRPT

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
QFA
Quattro Financial Advisors The Woodlands, Texas $468M AUM 13.49% 1-Year Est. Return

Assenagon Asset Management's SRPT Position: Q2 2026 in Review

Assenagon Asset Management opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 454,375 shares worth $8.17M. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: Assenagon Asset Management previously reported a position in SRPT as recently as Q3 2025.

Assenagon Asset Management first reported a position in SRPT in Q4 2018 and has held it in 21 quarters since. The position peaked at $125M in Q3 2022. 28 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Assenagon Asset Management held 454,375 shares of Sarepta Therapeutics worth $8.17M as of Q2 2026.
  • Sarepta Therapeutics was a new Assenagon Asset Management position in Q2 2026.
  • Sarepta Therapeutics made up 0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #566 holding.
  • Assenagon Asset Management first reported a position in Sarepta Therapeutics in Q4 2018 and has held it in 21 quarters since.
  • Assenagon Asset Management's Sarepta Therapeutics position peaked at $125M in Q3 2022.
  • 28 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.